Institutional Ownership Biocryst Pharmaceuticals Inc (BCRX)
This table provides information about the institutional ownership of Biocryst Pharmaceuticals Inc (BCRX). We have compiled data on the 310 institutions that hold shares in the stock, with a total of 200 Million shares, which have been reported (via 13F filing form) to have a value of $1.42 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
1,892,043
shares
|
$13.4 Million
0.0% of portfolio
|
Q3 2025
Reduced 1.13%
|
|
|
Rice Hall James & Associates, LLC
|
Oct 16, 2025 Q3 2025 |
1,880,389
shares
|
$13.3 Million
0.83% of portfolio
|
Q3 2025
Reduced 8.73%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
1,848,346
shares
|
$13.1 Million
0.0% of portfolio
|
Q3 2025
Added 563.68%
|
|
|
Stifel Financial Corp
St. Louis, MO |
Nov 12, 2025 Q3 2025 |
1,822,992
shares
|
$12.9 Million
0.01% of portfolio
|
Q3 2025
Reduced 0.02%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2025 Q3 2025 |
1,709,336
shares
|
$12.1 Million
0.01% of portfolio
|
Q3 2025
Reduced 61.06%
|
|
|
Eversept Partners, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
1,373,625
shares
|
$9.73 Million
0.81% of portfolio
|
Q3 2025
Added 13.74%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
1,359,882
shares
|
$9.63 Million
0.0% of portfolio
|
Q3 2025
Reduced 46.83%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,250,000
shares
|
$8.85 Million
0.13% of portfolio
|
Q3 2025
Reduced 72.22%
|
|
|
Cubist Systematic Strategies, LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
1,246,696
shares
|
$8.83 Million
0.05% of portfolio
|
Q3 2025
New holding
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Nov 18, 2025 Q3 2025 |
1,196,319
shares
|
$8.47 Million
0.01% of portfolio
|
Q3 2025
Added 23.45%
|
|
|
Segall Bryant & Hamill, LLC
Chicago, IL |
Nov 12, 2025 Q3 2025 |
1,134,813
shares
|
$8.03 Million
0.12% of portfolio
|
Q3 2025
Reduced 6.99%
|
|
|
Jpmorgan Chase & CO
New York, NY |
Nov 26, 2025 Q3 2025 |
1,132,377
shares
|
$8.02 Million
0.0% of portfolio
|
Q3 2025
Added 6.27%
|
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
1,108,660
shares
|
$7.85 Million
0.01% of portfolio
|
Q3 2025
Added 53.27%
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
1,069,015
shares
|
$7.57 Million
0.0% of portfolio
|
Q3 2025
Added 129.49%
|
|
|
Parkman Healthcare Partners LLC
Stamford, CT |
Nov 14, 2025 Q3 2025 |
1,012,664
shares
|
$7.17 Million
0.96% of portfolio
|
Q3 2025
Added 0.46%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
999,785
shares
|
$7.08 Million
0.01% of portfolio
|
Q3 2025
Reduced 12.97%
|
|
|
Invesco Ltd.
Atlanta, GA |
Nov 13, 2025 Q3 2025 |
962,376
shares
|
$6.81 Million
0.0% of portfolio
|
Q3 2025
Reduced 3.1%
|
|
|
Voloridge Investment Management, LLC
Jupiter, FL |
Nov 14, 2025 Q3 2025 |
957,021
shares
|
$6.78 Million
0.03% of portfolio
|
Q3 2025
Reduced 61.32%
|
|
|
Jump Financial, LLC
Chicago, IL |
Nov 13, 2025 Q3 2025 |
924,776
shares
|
$6.55 Million
0.08% of portfolio
|
Q3 2025
Reduced 31.35%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
901,500
shares
|
$6.38 Million
0.23% of portfolio
|
Q3 2025
New holding
|
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Nov 13, 2025 Q3 2025 |
848,562
shares
|
$6.01 Million
0.02% of portfolio
|
Q3 2025
Reduced 32.53%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
839,403
shares
|
$5.94 Million
0.01% of portfolio
|
Q3 2025
Added 125.78%
|
|
|
Tang Capital Management LLC
San Diego, CA |
Nov 14, 2025 Q3 2025 |
800,000
shares
|
$5.66 Million
0.28% of portfolio
|
Q4 2023
Reduced 67.35%
|
|
|
Barclays PLC
London, X0 |
Nov 12, 2025 Q3 2025 |
782,232
shares
|
$5.54 Million
0.0% of portfolio
|
Q3 2025
Reduced 2.72%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 12, 2025 Q3 2025 |
734,987
shares
|
$5.2 Million
0.0% of portfolio
|
Q3 2025
Added 1.03%
|
|